This systematic review synthesized evidence from 65 studies examining >65 helminth-derived immunomodulatory peptides, polypeptides, and proteins (HDIPs) across animal models of inflammatory disease. HDIPs consistently reduced disease severity, decreased pro-inflammatory cytokines, and increased anti-inflammatory cytokines, highlighting their broad disease-modifying potential and promise as novel immunoregulatory therapeutics.